888
Downloads
19
Episodes
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Episodes
Thursday Mar 14, 2024
Making Undruggable Targets a Thing of the Past
Thursday Mar 14, 2024
Thursday Mar 14, 2024
Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address big challenges that plague the industry, and why the company is agnostic to drug modality.
Thursday Feb 22, 2024
Using AI to Revolutionize Precision Oncology
Thursday Feb 22, 2024
Thursday Feb 22, 2024
In this episode Tuvik Beker, CEO of Pangea Biomed, sits down with Dr. Amar Drawid to discuss the evolution of precision medicine, the challenges in matching the right drugs to the right patient, and how Pangea uses AI to analyze expression data and gene interaction maps to select the most effective drugs for individual patients.
Tuesday Jan 30, 2024
Leveraging Data Analytics to Enhance Biopharma Sales
Tuesday Jan 30, 2024
Tuesday Jan 30, 2024
Data analytics has evolved significantly in the pharmaceutical industry, providing sales professionals with better insights and decision-making capabilities. On this episode, Dr. Amar Drawid sits down with 40-year biopharmaceutical industry veteran Jonathan Blutfield, principal consultant with TriRadial Solutions, to discuss the evolution of data analytics for commercial teams, how sales reps play a vital role in personalizing interactions with healthcare professionals, and how companies can enhance the effectiveness of data analytics tools and integrate them into their sales strategies.
Dr. Amar Drawid
Dr. Amar Drawid is the host of Life Science D’n’A podcast and currently serves as chief AI and business consulting officer for Agilisium Consulting. For nearly 25 years, he has worked in bioinformatics, data analytics, and AI within the life sciences industry with such companies as Sanofi, Celgene, and Novartis. He holds an M.S. and B.S. in bioinformatics, computer science, and molecular biophysics and biochemistry from Yale University and a Ph.D. in computational biology and molecular biophysics (artificial intelligence/machine learning) from Rutgers University